$64.760
+0.913 (+1.41%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RPRX por análisis de gráficos similares
Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $64.98 (+0.34%). The 1-week path is $65.76 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Royalty Pharma PLC?
Royalty Pharma PLC is a good buy right now due to its current price of $63.86 being below the average analyst price target of $66, suggesting a potential upside of approximately 3.5%. Additionally, the company has shown strong financial performance with a year-to-date change of +64.33% and a robust gross margin of 100%. The main risk is the high RSI of 82.353, indicating that the stock may be overbought in the short term, which could lead to volatility.
RPRX cerró en $64.76 el Monday, tras subir +1.41%
Royalty Pharma PLC (RPRX) last closed at $64.7600021, gaining +1.41%. These facts feed the 1-day and 1-week RPRX price prediction above.
Factores de la previsión
Los factores de la previsión de Royalty Pharma PLC (RPRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RPRX, ordenadas por similitud.
Análisis de estacionalidad de RPRX
Historically the probability of a positive October return for RPRX is 64.06%. March offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.